-

Abacus Global Management, Inc. (NASDAQ: ABL) Under Investigation Following “Fake Revenue” Allegations; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Abacus Global Management, Inc. (“Abacus”) fell over 30% in intraday trading on Wednesday, June 4, 2025, after Morpheus Research published an article alleging that the financial services company is a “life settlements accounting scheme manufacturing fake revenue by systematically underestimating when people will die.” Gibbs Mura is investigating a potential Abacus Global Management, Inc. (NASDAQ: ABL) Securities Class Action Lawsuit on behalf of shareholders who lost money in Abacus.

On June 4, 2025, Morpheus Research published a detailed report alleging that Abacus is a “life settlements accounting scheme manufacturing fake revenue by systematically underestimating when people will die.”

Share

What Should Abacus Global Management, Inc. Investors Do?

If you invested in ABL, visit our Abacus Global Management, Inc. investigation webpage, or call us at (888) 410-2925 to get more information about how you may be able to recover your losses. Our investigation concerns whether Abacus has violated federal securities laws by providing false or misleading statements to investors.

What is the Abacus Global Management, Inc. (ABL) Lawsuit Investigation About?

On June 4, 2025, Morpheus Research published a detailed report alleging that Abacus is a “life settlements accounting scheme manufacturing fake revenue by systematically underestimating when people will die.”

Morpheus’s three-month investigation into Abacus, which purportedly included expert interviews, review of corporate records and court documents, and discussions with former Abacus employees, allegedly uncovered that Abacus’s returns are “primarily manufactured by the systematic overvaluation of its assets through an opaque ‘mark to model’ accounting scheme that closely mirrors past blow-ups in the life settlements industry.”

The report claims that Abacus “has resorted to slashing its discount rate to generate more non-cash gains,” a tactic that has been linked to other notorious life settlement frauds such as GWG Holdings.

Following this news, shares of Abacus Global Management, Inc. plummeted over 30% in intraday trading on June 4, 2025, causing significant harm to investors.

About Gibbs Mura, A Law Group

Gibbs Mura represents investors nationwide in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

CATHERINE CONROY
510.350.9705
CRC@CLASSLAWGROUP.COM

Gibbs Mura

NASDAQ:ABL

Release Versions
$Cashtags

Contacts

CATHERINE CONROY
510.350.9705
CRC@CLASSLAWGROUP.COM

More News From Gibbs Mura

Top Plaintiff Firms Join Forces for Law Students: The Mason Gibbs Plaintiffs' Pathway Fellowship

OAKLAND, Calif.--(BUSINESS WIRE)--The Mason Gibbs Plaintiffs’ Pathway Fellowship has now launched, offering exceptional 1L law students the opportunity to spend their summer at leading plaintiff firms across the country holding corporations accountable for misconduct and protecting the rights of ordinary individuals. Students will have the opportunity to be placed in the summer of 2026 at Gibbs Mura LLP, in Oakland, CA; Singleton Schreiber, with 17 offices in different cities; Koskoff Koskoff &...

Ardent Health, Inc. (ARDT) Under Investigation After Shares Plummet Over 33%

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is investigating a potential securities class action lawsuit on behalf of Ardent Health, Inc. (NYSE: ARDT) investors....

Lawsuit Filed Against Stride, Inc. (LRN) After Shares Plummet Over 51%

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura announces that a class action lawsuit has been filed against Stride, Inc. (“Stride”) on behalf of investors who purchased or acquired Stride securities between October 22, 2024 and October 28, 2025. Shares of Stride, Inc. plummeted over 51% in intraday trading on October 29, 2025, after the company reported a weak 2026 financial forecast, citing platform upgrades that resulted in a “poor customer experience” and a large decrease in enrollment numbers...
Back to Newsroom